Hazard
270 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 270 dissolution failure recalls we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 10 (4%) are Severe.
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all dissolution failure recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Biogen is recalling 5,307 bottles of Vumerity capsules because they failed dissolution testing. The medication may not release the drug as intended.
Golden State Medical Supply is recalling Aripiprazole 15 mg tablets due to potential out-of-specification dissolution limits.
The Harvard Drug Group is recalling 841 cartons of Aripiprazole Tablets, 15 mg, because the product failed to meet dissolution specifications.
Apotex Corp. is recalling Aripiprazole Tablets 15 mg because they failed to meet dissolution specifications. The affected products were distributed nationwide in the USA.
Teva Pharmaceuticals is recalling 133,829 bottles of Mesalamine Delayed-Release Tablets because stability testing revealed out-of-specification dissolution results.
RemedyRepack Inc. is recalling Carbamazepine 200 mg tablets because routine stability testing revealed low dissolution results.
Pfizer is recalling Duavee tablets because they failed to meet dissolution specifications. The recall covers 544,400 packages distributed nationwide.
American Health Packaging is recalling Doxycycline Hyclate 100 mg tablets because they failed to meet dissolution specifications at the end of their shelf life.
The Harvard Drug Group is recalling Doxycycline Hyclate tablets because they failed a dissolution test at the end of their shelf life.
West-Ward Columbus Inc. is recalling Doxycycline Hyclate 100 mg tablets because they failed a dissolution test at the end of their shelf life.
The Harvard Drug Group is recalling 678 cartons of Memantine Hydrochloride Extended-Release Capsules due to low stage 3 dissolution results found during routine stability testing.
Avet Pharmaceuticals is recalling 17,524 bottles of Tetracycline Hydrochloride 500 mg capsules because they failed dissolution specifications during long-term testing.
Avet Pharmaceuticals is recalling Tetracycline Hydrochloride capsules due to out-of-specification dissolution results found during long-term testing.
Teva Pharmaceuticals USA is recalling 3,695 bottles of Mesalamine Delayed-Release Tablets because stability testing showed low dissolution results.
American Health Packaging is recalling 973 cartons of Raloxifene Hydrochloride 60 mg tablets due to low dissolution results found during stability testing.
Lupin Pharmaceuticals is recalling 6,294 bottles of Memantine Hydrochloride Extended Release Capsules because they failed to meet dissolution specifications during stability testing.
Ascend Laboratories is recalling Minocycline Hydrochloride Extended-Release Tablets due to low dissolution test results.
Macleods Pharma USA is recalling 10,680 bottles of Montelukast Sodium Chewable Tablets, 5 mg, because testing revealed low out-of-specification dissolution results in one lot.
Lupin Pharmaceuticals is recalling 3,726 bottles of Memantine Hydrochloride Extended-release Capsules because stability studies showed high out-of-specification dissolution results.
Mylan Pharmaceuticals is recalling 4,272 bottles of Prasugrel 5 mg tablets because they failed to meet dissolution specifications.
EPI Health is recalling 1,626 bottles of Minolira extended-release tablets because they failed dissolution specifications. The recall is limited to EPI field representatives.
Upsher-Smith Laboratories is recalling 166 bottles of Bexarotene 75 mg capsules because they failed to meet dissolution specifications.
Macleods Pharma USA Inc is recalling Tamsulosin Hydrochloride Capsules because they failed to meet dissolution specifications.
Jubilant Cadista Pharmaceuticals is recalling specific lots of Drospirenone and Ethinyl Estradiol Tablets because they failed dissolution specifications during stability testing.
American Health Packaging is recalling Doxycycline Hyclate 100 mg tablets because they failed to meet dissolution specifications. The affected lot was distributed nationwide.